Groundbreaking stabilization & delivery enabling technology for your microbial and biological products
Our mission is to become the leading global provider of biological stabilization and drug delivery solutions by offering our customers the most advanced formulation science and preservation technology available for the protection of their products from impacts to potency and effectiveness during long-term storage, transport, and distribution.
Reach out to us to learn more about how our solutions can help you.
The human body is home to trillions of microorganisms including bacteria, viruses, and fungi. As we learn more about the potential microbiome modulating microbes have on human health, it is clear product companies need an effective alternative to lyophilization to produce beneficial bacteria without losses in therapeutic value during manufacture and subsequent storage.
Ensuring the efficacy, stability, and commercial viability of microbial products and their metabolites in real world conditions are among the biggest challenges in agriculture. To reduce the environmental impact of farming while enhancing crop production, growers must see improvements in yield, longer shelf life, and compatibility with agrochemicals.
From live attenuated viral and bacterial vaccines to therapeutic proteins, blood components, and highly reactive and unstable pharmaceuticals, UST has a long track record of applying novel technologies for the stabilization of labile biological drugs suitable for conventional delivery or formulated for mucosal delivery without reconstitution.
Universal Stabilization Technologies, Inc. ("UST") is a San Diego-based biopharmaceutical R&D company and provider of leading stabilization and delivery enabling technologies with higher yields and at higher storage temperatures than currently possible. UST’s proprietary process allows the cost-effective stabilization and delivery of fragile biologicals from biomedical to agricultural applications during long-term storage, transport, and distribution. UST also develops novel methods for mucosal and transdermal administration of labile biologicals.
© 2020 Universal Stabilization Technologies, Inc. All rights reserved.